References
- De Jonckheere JF. Origin and evolution of the worldwide distributed pathogenic amoeboflagellate Naegleria fowleri. Infect Genet Evol 2011; 11: 1520-1528. https://doi.org/10.1016/j.meegid.2011.07.023
- Jarolim KL, McCosh JK, Howard MJ, John DT. A light microscopy study of the migration of Naegleria fowleri from the nasal submucosa to the central nervous system during the early stage of primary amebic meningoencephalitis in mice. J Parasitol 2000; 86: 50-55. https://doi.org/10.1645/0022-3395(2000)086[0050:ALMSOT]2.0.CO;2
- Fowler M, Carter RF. Acute pyogenic meningitis probably due to Acanthamoeba sp.: a preliminary report. Br Med J 1965; 2: 740-742.
- Cope JR, Ali IK. Primary amebic meningoencephalitis: what have we learned in the last 5 years? Curr Infect Dis Rep 2016; 18: 31-37. https://doi.org/10.1007/s11908-016-0539-4
- Grace E, Asbill S, Virga K. Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options. Antimicrob Agents Chemother 2015; 59: 6677-6681. https://doi.org/10.1128/AAC.01293-15
- Capewell LG, Harris AM, Yoder JS, Cope JR, Eddy BA, Roy SL, Visvesvara GS, Fox LM, Beach MJ. Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937-2013. J Pediatric Infect Dis Soc 2015; 4: 68-75. https://doi.org/10.1093/jpids/piu103
- Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 2007; 50: 1-26. https://doi.org/10.1111/j.1574-695X.2007.00232.x
- Carter RF. Sensitivity to amphotericin B of a Naegleria sp. related from a case of primary amoebic encephalitis. J Clin Pathol 1969; 22: 470-474. https://doi.org/10.1136/jcp.22.4.470
- Seidel JS, Harmatz P, Visvesvara GS, Cohen A, Edwards J, Turner J. Successful treatment of primary amebic meningoencephalitis. N Engl J Med 1982; 306: 346-348. https://doi.org/10.1056/NEJM198202113060607
- Vargas-Zepeda J, Gomez-Alcala AV, Vasquez-Morales JA, Licea-Amaya L, De Jonckheere JF, Lares-Villa F. Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin. Arch Med Res 2005; 36: 83-86. https://doi.org/10.1016/j.arcmed.2004.11.003
- Centers for Disease Control and Prevention. May 2014. Atlanta, USA. N. fowleri treatment. Centers for Disease Control and Prevention.
Cited by
- Understanding the true burden of “Naegleria fowleri” (Vahlkampfiidae) in patients from Northern states of India: Source tracking and significance vol.76, 2019, https://doi.org/10.1016/j.ejop.2020.125726
- Photolysis of sodium chloride and sodium hypochlorite by ultraviolet light inactivates the trophozoites and cysts of Acanthamoeba castellanii in the water matrix vol.19, pp.1, 2019, https://doi.org/10.2166/wh.2020.401
- Drugs used for the treatment of cerebral and disseminated infections caused by free‐living amoebae vol.14, pp.3, 2019, https://doi.org/10.1111/cts.12955
- Death From Primary Amebic Meningoencephalitis After Recreational Water Exposure During Recent Travel to India-Santa Clara County, California, 2020 vol.8, pp.8, 2019, https://doi.org/10.1093/ofid/ofab322